The Association between ABCB1 C1236T/C3435T SNPs and H. pylori Infection among Jordanians
暂无分享,去创建一个
[1] Hells Mesa Tuff. Previous , 2020, Definitions.
[2] T. Kanai,et al. Previous Helicobacter pylori infection–induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication , 2019, Helicobacter.
[3] F. F. de Melo,et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection , 2019, World journal of gastroenterology.
[4] I. Mitov,et al. Multidrug resistance in Helicobacter pylori: current state and future directions , 2019, Expert review of clinical pharmacology.
[5] F. Pourfarzi,et al. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives , 2019, Cancer medicine.
[6] M. Curado,et al. Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: A systematic review and meta-analysis. , 2019, Cancer epidemiology.
[7] Y. Yamaoka,et al. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam , 2019, Gut and liver.
[8] I. Maev,et al. [Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy]. , 2017, Terapevticheskii arkhiv.
[9] D. Scott,et al. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors , 2017, Current Gastroenterology Reports.
[10] R. Malekzadeh,et al. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran , 2017, Digestive Diseases and Sciences.
[11] Jun Chen,et al. Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients , 2017, Wiener klinische Wochenschrift.
[12] Manfred Uhr,et al. ABCB1 genotyping in the treatment of depression. , 2016, Pharmacogenomics.
[13] J. Ford,et al. Genetic predisposition to gastric cancer. , 2016, Seminars in oncology.
[14] Jianhua Lin,et al. Etiology and Prevention of Gastric Cancer , 2016, Gastrointestinal Tumors.
[15] T. Cover. Helicobacter pylori Diversity and Gastric Cancer Risk , 2016, mBio.
[16] Wentao Liu,et al. New blood markers detection technology: A leap in the diagnosis of gastric cancer. , 2016, World journal of gastroenterology.
[17] R. Vilaichone,et al. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[18] H. Saito,et al. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype. , 2015, World journal of gastroenterology.
[19] H. Lerche,et al. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature , 2015, Clinical Pharmacokinetics.
[20] L. Shen,et al. [Association between ABCB1 G2677T/A polymorphisms and chemosensitivity of paclitaxel in advanced gastric cancer]. , 2015, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
[21] D. Jesionek-Kupnicka,et al. Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary research. , 2014, Pathology, research and practice.
[22] Deng-Chyang Wu,et al. CYP2C19 polymorphism influences Helicobacter pylori eradication. , 2014, World journal of gastroenterology.
[23] M. Al-Jarrah,et al. Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration , 2014, Experimental and therapeutic medicine.
[24] ZhouXiaojun,et al. Association Between the c.3073A>C Genetic Polymorphism of the MDR1 Gene and Susceptibility to Gastric Cancer in the Chinese Han Population , 2014 .
[25] N. Mhaidat,et al. The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians , 2015, Cytotechnology.
[26] A. Brambila-Tapia. MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[27] N. Mhaidat,et al. The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. , 2013, International journal of clinical pharmacology and therapeutics.
[28] Li Zhang,et al. Association between single genetic polymorphisms of MDR1 gene and gastric cancer susceptibility in Chinese , 2013, Medical Oncology.
[29] S. Staibano,et al. MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells , 2012, Laboratory Investigation.
[30] R. Parsons,et al. P‐glycoprotein expression in Helicobacter pylori‐positive patients: The influence of MDR1 C3435T polymorphism , 2012, Journal of digestive diseases.
[31] N. Forones,et al. Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. , 2012, Molecular medicine reports.
[32] Y. Li,et al. MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[33] J. Behravan,et al. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. , 2010, Indian journal of cancer.
[34] T. Tahara,et al. Promoter Methylation Status of Multidrug Resistance 1 (MDR1) Gene in Noncancerous Gastric Mucosa Correlates With Helicobacter Pylori Infection and Gastric Cancer Occurrence , 2010, Cancer investigation.
[35] W. Marlicz,et al. Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole , 2010, European Journal of Clinical Pharmacology.
[36] T. Tahara,et al. Influence of MDR1 Polymorphism on H. pylori-Related Chronic Gastritis , 2010, Digestive Diseases and Sciences.
[37] T. Tahara,et al. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. , 2009, Anticancer research.
[38] H. Sugimura,et al. MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. , 2008, Life sciences.
[39] T. Tahara,et al. Multi‐drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population , 2007, Journal of gastroenterology and hepatology.
[40] Adorjan Aszalos,et al. Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. , 2007, Drug discovery today.
[41] Supratim Choudhuri,et al. Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters , 2006, International journal of toxicology.
[42] K. Safranow,et al. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection , 2005, European Journal of Clinical Pharmacology.
[43] R. Laheij,et al. The importance of corpus biopsies for the determination of Helicobacter pylori infection. , 2005, The Netherlands journal of medicine.